Neutralization escape of emerging subvariants XBB.1.5/1.9.1 and XBB.2.3 from current therapeutic monoclonal antibodies.

Chye, De Hoe; Chew, Charmaine W Y; Yeo, He Ping; Tambyah, Paul A; Young, Barnaby E; Tan, Gladys G Y; Tan, Boon Huan; Vasoo, Shawn; Chan, Conrad E Z

Chye, De Hoe; Chew, Charmaine W Y; Yeo, He Ping; Tambyah, Paul A; Young, Barnaby E; Tan, Gladys G Y; Tan, Boon Huan; Vasoo, Shawn; Chan, Conrad E Z.

Afiliação

Chye H; DSO National Laboratories, Defence Medical and Environmental Research Institute, Singapore, Singapore.
Chew CWY; National Centre for Infectious Diseases, Singapore, Singapore.
Yeo HP; National Centre for Infectious Diseases, Singapore, Singapore.
Tambyah PA; Department of Medicine, Infectious Diseases Translational Research Program, Division of Infectious Diseases, National University Hospital, National University of Singapore, Singapore, Singapore.
Young BE; National Centre for Infectious Diseases, Singapore, Singapore.
Tan GGY; Tan Tock Seng Hospital, Singapore, Singapore.
Tan BH; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Vasoo S; DSO National Laboratories, Defence Medical and Environmental Research Institute, Singapore, Singapore.
Chan CEZ; DSO National Laboratories, Defence Medical and Environmental Research Institute, Singapore, Singapore.

J Med Virol ; 95(9): e29074, 2023 09.

Article em En | MEDLINE | ID: mdl-37665160

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Med Virol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Singapura

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google